COPD is a common, preventable and treatable disease characterized by chronic airflow limitation that is not fully reversible and is associated with an enhanced chronic inflammatory response of the airways and lungs to particles or harmful gases.1 COPD is a combination of chronic bronchitis and emphysema. The clinical term is defined as chronic bronchitis and the anatomical physiology is defined as emphysema. Both small airway disease and parenchymal destruction contribute to chronic airflow limitation. COPD is correlated with a history of cigarette smoking, which has become the third leading cause of death in the United States.2 In 2011, the prevalence of COPD was 6.3% (an estimated 15 million), but varies by age , race/ethnicity, gender, and status. The prevalence of COPD increased from 3.2% among those aged 18 to 44 years to >11.6% among those aged >65 years. The most common risk factor for COPD is tobacco smoking, which includes cigarettes, cigars, pipes, environmental tobacco smoke, and other products available in other countries.3 The risk factor for SCI is cigarette smoking. The other important risk factor is the burning of biomass fuel, which therefore causes external, internal and occupational air pollution. Severe hereditary alpha-1 antitrypsin deficiency is a genetic risk factor that may contribute to COPD. Even non-smokers can develop COPD. The likelihood of diagnosing COPD increases when an individual presents with symptoms of dyspnea, chronic cough or sputum production, and a history of exposure to risk factors.3 Dyspnea is a cardinal symptom of COPD, which is a leading cause of disability and anxiety associated with the disease. The first symptom of COPD is chronic cough. Initially, it may be intermittent and later occur every day and... half of the article......nic Obstructive Lung Disease (GOLD) 2014. Available from: http://www.goldcopd.org/ .4. Chee A, shame DD. Treatment of mild chronic obstructive pulmonary disease. Int J Chron Obstruct lung Dis. 2008;3(4):563-573.5. Bartlett YK, Sheeran P, Hawley MS. Effective behavior change techniques in smoking cessation interventions for people with chronic obstructive pulmonary disease: a meta-analysis. Br J Health psychologist. 2014;19(1):181-203. doi:10.1111/bjhp.12071.6. GOLD Patient Guide: What you can do about a lung disease called COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014. Available at: http://www.goldcopd.org/.7. Albuterol (inhaled) Correct use - Drugs and supplements - Mayo Clinic. Available at: http://www.mayoclinic.org/drugs-supplements/albuterol-inhalation-route/proper-use/drg-20073536. Accessed May 30th, 2014.